Skip to main content
Journal of Pediatric Ophthalmology & Strabismus, 2011;48(2):92–97
Published Online:https://doi.org/10.3928/01913913-20100420-02Cited by:24

Abstract

Purpose:

To evaluate contrast sensitivity in children and adolescents with diabetes mellitus without evidence of diabetic retinopathy.

Methods:

Sixty patients with insulin-dependent diabetes mellitus (age range: 8 to 18 years) were studied. Their contrast sensitivity scores were obtained using the CSV-1000 device (Vector Vision, Dayton, OH) for four spatial frequencies and were compared with v scores of 45 age-matched and gender-matched “healthy” patients. Contrast sensitivity values were also correlated to patient’s age, duration of disease, and metabolic control of diabetes mellitus.

Results:

The patients with insulin-dependent diabetes mellitus had a significant contrast sensitivity score reduction at all spatial frequencies tested. Glycosylated hemoglobin levels were inversely related to the contrast sensitivity thresholds. No significant correlation was found between the contrast sensitivity scores and the patient’s age or duration of disease.

Conclusion:

Contrast sensitivity defects are detected in patients with insulin-dependent diabetes mellitus. These defects may represent an early dysfunction of the retina, visual pathway, or both in patients with insulin-dependent diabetes mellitus who do not show any signs of diabetic retinopathy.

  • 1.Centers for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults–United States, 1999–2000. MMWR Morb Mortal Wkly Rep. 2003; 52:833–837.

    > MedlineGoogle Scholar
  • 2.Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984; 102:520–526.

    > Crossref MedlineGoogle Scholar
  • 3.Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984; 102:527–532.

    > Crossref MedlineGoogle Scholar
  • 4.Sekuler R, Hutman LP, Owsley CJ. Human aging and spatial vision. Science. 1980; 209:1255–1256.10.1126/science.7403884

    > Crossref MedlineGoogle Scholar
  • 5.Zimmern RL, Campbell FW, Wilkinson IM. Subtle disturbances of vision after optic neuritis elicited by studying contrast sensitivity. J Neurol Neurosurg Psychiatry. 1979; 42:407–412.10.1136/jnnp.42.5.407

    > Crossref MedlineGoogle Scholar
  • 6.Ross JE, Bron AJ, Clarke DD. Contrast sensitivity and visual disability in chronic simple glaucoma. Br J Ophthalmol. 1984; 68:821–827.10.1136/bjo.68.11.821

    > Crossref MedlineGoogle Scholar
  • 7.Brinchmann-Hansen O, Bangstad HJ, Hultgren S, et al.Psychophysical visual function, retinopathy, and glycemic control in insulin-dependent diabetics with normal visual acuity. Acta Ophthalmol (Copenh). 1993; 71:230–237.10.1111/j.1755-3768.1993.tb04996.x

    > Crossref MedlineGoogle Scholar
  • 8.Ghafour IM, Foulds WS, Allan D, McClure E. Contrast sensitivity in diabetic patients with and without retinopathy. Br J Ophthalmol. 1982; 66:492–495.10.1136/bjo.66.8.492

    > Crossref MedlineGoogle Scholar
  • 9.Dosso AA, Bonvin ER, Morel Y, Golay A, Assal JP, Leuenberger PM. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 1996; 234:300–305.10.1007/BF00220704

    > Crossref MedlineGoogle Scholar
  • 10.Hardy KJ, Lipton J, Scase MO, Foster DH, Scarpello JHB. Detection of color vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. Br J Ophthalmol. 1992; 76:461–464.10.1136/bjo.76.8.461

    > Crossref MedlineGoogle Scholar
  • 11.Bresnick GH, Korth K, Groo A, Palta M. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy: preliminary report. Arch Ophthalmol. 1984; 102:1307–1311.

    > Crossref MedlineGoogle Scholar
  • 12.Uccioli L, Parisi V, Monticone G, et al.Electrophysiological assessment of visual function in newly-diagnosed IDDM patients. Diabetologia. 1995; 38:804–808.10.1007/s001250050356

    > Crossref MedlineGoogle Scholar
  • 13.Wanger P, Persson HE. Early diagnosis of retinal changes in diabetes: a comparison between electroretinography and retinal biomicroscopy. Acta Ophthalmol. 1985; 63:716–720.

    > CrossrefGoogle Scholar
  • 14.Sokol S, Moskowitz A, Skarf B, Evans R, Molitch M, Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol. 1985; 103:51–54.

    > Crossref MedlineGoogle Scholar
  • 15.Mackie SW, Walsh G. Contrast and glare sensitivity in diabetic patients with and without pan-retinal photocoagulation. Ophthalmic Physiol Opt. 1998; 18:173–181.10.1016/S0275-5408(97)00083-5

    > Crossref MedlineGoogle Scholar
  • 16.Fischer ML, Cole RG. Functional evaluation of the adult: optometric and ophthalmological evaluation. In: , Silverstone B, Long MA, Rosenthal BP, Faye EE, eds. Lighthouse Handbook on Vision Impairment and Vision Rehabilitation, vol. 2. New York: Oxford University Press; 2000:833–853.

    > Google Scholar
  • 17.Hyvärinen L. Considerations in evaluation and treatment of the child with low vision. Am J Occup Ther. 1995; 49:891–897.

    > Crossref MedlineGoogle Scholar
  • 18.Leat SJ, Woo GC. The validity of current clinical tests of contrast sensitivity and their ability to predict reading speed in low vision. Eye. 1997; 11:893–899.

    > Crossref MedlineGoogle Scholar
  • 19.West SK, Rubin GS, Broman AT, Muñoz B, Bandeen-Roche K, Turano K. How does visual impairment affect performance on tasks of everyday life? The SEE Project. Salisbury Eye Evaluation. Arch Ophthalmol. 2002; 120:774–780.

    > Crossref MedlineGoogle Scholar
  • 20.Leat SJ, Wegmann D. Clinical testing of contrast sensitivity in children: age-related norms and validity. Optom Vis Sci. 2004; 81:245–254.10.1097/00006324-200404000-00010

    > Crossref MedlineGoogle Scholar
  • 21.Sisto D, Trojano M, Vetrugno M, Trabucco T, Iliceto G, Sborgia C. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci. 2005; 46:1264–1268.10.1167/iovs.03-1213

    > Crossref MedlineGoogle Scholar
  • 22.Gandolfi SA, Cimino L, Sangermani C, Ungaro N, Mora P, Tardini MG. Improvement of spatial contrast sensitivity threshold after surgical reduction of intraocular pressure in unilateral high-tension glaucoma. Invest Ophthalmol Vis Sci. 2005; 46:197–201.10.1167/iovs.04-0199

    > Crossref MedlineGoogle Scholar
  • 23.Hilton EJ, Cubbidge RP, Hosking SL, Betts T, Comaish IF. Patients treated with vigabatrin exhibit central visual function loss. Epilepsia. 2002; 43:1351–1359.10.1046/j.1528-1157.2002.00502.x

    > Crossref MedlineGoogle Scholar
  • 24.Chatzistefanou KI, Theodossiadis GP, Damanakis AG, Ladas ID, Moschos MN, Chimonidou E. Contrast sensitivity in amblyopia: the fellow eye of untreated and successfully treated amblyopes. J AAPOS. 2005; 9:468–474.10.1016/j.jaapos.2005.05.002

    > Crossref MedlineGoogle Scholar
  • 25.Gartaganis SP, Psyrojannis AJ, Koliopoulos JX, Mela EK. Contrast sensitivity function in patients with impaired oral glucose tolerance. Optom Vis Sci. 2001; 78:157–161.10.1097/00006324-200103000-00008

    > Crossref MedlineGoogle Scholar
  • 26.Krásný J, Brunnerová R, Průhová S, et al.The contrast sensitivity test in early detection of ocular changes in children, teenagers, and young adults with diabetes mellitus type I [article in Czech]. Cesk Slov Oftalmol. 2006; 62:381–394.

    > MedlineGoogle Scholar
  • 27.Verrotti A, Lobefalo L, Petitti MT, et al.Relationship between contrast sensitivity and metabolic control in diabetics with and without retinopathy. Ann Med. 1998; 30:369–374.10.3109/07853899809029936

    > Crossref MedlineGoogle Scholar
  • 28.Mangouritsas G, Katoulis E, Kepaptsoglou O, Zoupas C. Effect of induced hyperglycemia on contrast sensitivity function in insulin-dependent diabetic patients [article in German]. Ophthalmologe. 1995; 92:142–147.

    > MedlineGoogle Scholar
  • 29.Hyvärinen L, Laurinen P, Rovamo J. Contrast sensitivity in evaluation of visual impairment due to diabetes. Acta Ophthalmol (Copenh). 1983; 61:94–101.10.1111/j.1755-3768.1983.tb01399.x

    > Crossref MedlineGoogle Scholar
  • 30.Moloney J, Drury MI. Retinopathy and retinal function in insulin-dependent diabetes mellitus. Br J Ophthalmol. 1982; 66:759–761.10.1136/bjo.66.12.759

    > Crossref MedlineGoogle Scholar
  • 31.Dosso AA, Yenice-Ustun F, Sommerhalder J, Golay A, Morel Y, Leuenberger PM. Contrast sensitivity in obese dyslipidemic patients with insulin resistance. Arch Ophthalmol. 1998; 116:1316–1320.

    > Crossref MedlineGoogle Scholar
  • 32.Banford D, North RV, Dolben J, Butler G, Owens DR. Longitudinal study of visual functions in young insulin dependent diabetics. Ophthalmic Physiol Opt. 1994; 14:339–346.10.1111/j.1475-1313.1994.tb00122.x

    > Crossref MedlineGoogle Scholar
  • 33.North RV, Farrell U, Banford D, et al.Visual function in young IDDM patients more than 8 years of age: a 4-year longitudinal study. Diabetes Care. 1997; 20:1724–1730.10.2337/diacare.20.11.1724

    > Crossref MedlineGoogle Scholar
  • 34.Urban B, Bakunowicz-Lazarczyk A, Peczynska J, Urban M. The evaluation of contrast sensitivity in children and adolescents with insulin-dependent diabetes mellitus [article in Polish]. Klin Oczna. 1999; 101:111–114.

    > MedlineGoogle Scholar
  • 35.Liska V. Contrast sensitivity in type I diabetics without symptoms of diabetic retinopathy [article in Czech]. Cesk Slov Oftalmol. 1999; 55:237–245.

    > MedlineGoogle Scholar
  • 36.Yamagishi S, Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des. 2005; 11:2279–2299.10.2174/1381612054367300

    > Crossref MedlineGoogle Scholar
  • 37.Sato T, Iwaki M, Shimogaito N, Wu X, Yamagishi S, Takeuchi M. TAGE (toxic AGEs) theory in diabetic complications. Curr Mol Med. 2006; 6:351–358.10.2174/156652406776894536

    > Crossref MedlineGoogle Scholar
  • 38.Yamagishi S, Matsui T, Nakamura K. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes. Curr Drug Targets. 2007; 8:1138–1143.10.2174/138945007782151298

    > Crossref MedlineGoogle Scholar
  • 39.Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des. 2008; 14:962–968.10.2174/138161208784139729

    > Crossref MedlineGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×